Literature DB >> 9163068

Species specificity of anticoagulant activity of activated human protein C: involvement of factor V as well as protein S.

Y Katsuura1, T Mochizuki, M Tamura, S Hoshide, M Kiyoki, T Nakagaki, S Miyamoto.   

Abstract

Activated protein C (APC) possesses species specificity in its anticoagulant activity. Human APC exerts only weak activity in rat plasma compared with that in human plasma. The present study was undertaken to estimate the difference in interaction of human and rat factors with human APC and to assess the cause of the species specificity. Human or rat protein S (PS), factor V, or factor VIII was used to supplement human plasma depleted of each respective factor, and the anticoagulant activity of human APC was measured in term of the elongation of activated partial thromboplastin time (APTT). The activity of human APC in rat PS- or factor V-supplemented plasma was weaker than that in the human PS- or factor V-supplemented plasma. Furthermore, using purified human and rat factor V, human APC showed weaker inactivation of rat factor V than human factor V. Equal anticoagulant activity was observed in human or rat factor VIII-supplemented plasma. And there was a little difference in the interaction of APC with its inhibitors in human or rat plasma during a few minutes of incubation as judged by measurement of residual activity by an enzyme capture assay. From these results factor V as well as PS seems to play a major role in the species specificity of APC.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9163068     DOI: 10.1016/0049-3848(96)00061-8

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  6 in total

1.  Comparison of the Therapeutic Effect of Allogeneic and Xenogeneic Small Extracellular Vesicles in Soft Tissue Repair.

Authors:  Jia Dong; Yue Wu; Yan Zhang; Mei Yu; Weidong Tian
Journal:  Int J Nanomedicine       Date:  2020-09-22

2.  Species-specific anticoagulant and mitogenic activities of murine protein S.

Authors:  José A Fernández; Mary J Heeb; Xiao Xu; Itender Singh; Berislav V Zlokovic; John H Griffin
Journal:  Haematologica       Date:  2009-10-08       Impact factor: 9.941

3.  Therapeutic levels of human protein C in rats after retroviral vector-mediated hepatic gene therapy.

Authors:  S R Cai; S C Kennedy; W M Bowling; M W Flye; K P Ponder
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

4.  Activated protein C induces endoplasmic reticulum stress and attenuates lipopolysaccharide-induced apoptosis mediated by glycogen synthase kinase-3β.

Authors:  Liang Luo; Tangfeng Lv; Qian Wang; Ting Zhang; Xiaoling Gu; Feng Xu; Yong Song
Journal:  Mediators Inflamm       Date:  2012-05-28       Impact factor: 4.711

5.  Activated protein C improves intestinal microcirculation in experimental endotoxaemia in the rat.

Authors:  Christian Lehmann; Konrad Meissner; Andreas Knöck; Stephan Diedrich; Dragan Pavlovic; Matthias Gründling; Taras Usichenko; Michael Wendt; Jürgen Birnbaum
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

6.  Human activated protein C variants in a rat model of arterial thrombosis.

Authors:  Karl Malm; Björn Arnljots; Björn Dahlbäck
Journal:  Thromb J       Date:  2008-10-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.